One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Advanced Wound Care Market

[ 英語タイトル ] Advanced Wound Care Market by Product (Dressings (Foams, Hydrocolloids, Alginates), Therapy Devices, NPWT, Autograft, Allograft, Xenograft), Wound (Surgical, Trauma, Diabetic Foot, Ulcers, Burns), End User (Hospital, Home Care) - Global Forecast to 2022


Product Code : MNMHC00108969
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global advanced wound care market projected to grow at a CAGR of 4.6% during the forecast period.”
The global advanced wound care market is expected to reach USD 13.07 billion by 2022 from USD 10.43 billion in 2017. Factors driving the growth of this market include the increasing prevalence of diabetic foot, pressure ulcers, venous leg ulcers, and other chronic wounds; increasing geriatric population; surging R&D activities in the field of wound care research; development of advanced wound care products; and increasing awareness programs for wound care treatment and management. On the other hand, the growth of this market is hindered to some extent due to the high cost of chronic wound treatment.
“The active wound care segment expected to grow at the fastest rate during the forecast period.”
The active wound care segment is anticipated to grow at the highest CAGR during the forecast period. The active wound care market is expected to witness growth during the forecast period owing to the rising geriatric population, increasing prevalence of diabetes and obesity, growing awareness of active wound products, and the increasing number of seniors living in long-term care facilities.
“The ulcers segment is anticipated to grow at the fastest growth rate during the forecast period.”
By wound type, the market is categorized into surgical wounds, ulcers, traumatic wounds, burns, and other wounds. The ulcers segment is estimated to grow at the fastest rate during the forecast period. Factors such as the rising incidence of pressure ulcers, diabetic foot ulcers, and venous ulcers and increasing geriatric population are the key factors driving the growth of this segment.
“The home healthcare segment is estimated to grow at a rapid rate during the forecast period.”
By end user, the advanced wound care market is segmented into hospitals and clinics, home care settings, and other end users. The home healthcare segment is expected to grow the fastest rate during the forecast period. The rapid growth in the aging population and rising incidence of chronic diseases are driving the demand for wound care products in this end-user segment. The need for advanced wound care products is especially high where surgical interventions, especially for orthopedics, vascular diseases, endoscopic surgeries, dermatological ulcers, bedsores, and burns, are involved. The increasing volume of surgical procedures and the need to control soaring healthcare costs are expected to increase the use of single-use disposable and portable systems such as negative pressure wound therapy (NPWT) that are used in home care settings.
“Asia Pacific is estimated to grow at the highest CAGR during the study period.”
Geographically, the advanced wound care market is dominated by North America, followed by Europe in 2017. The Asia Pacific region is estimated to grow at the fastest rate which can be attributed to the large population in China and India, increasing research in wound care, and increasing penetration of key players in the emerging markets of Asia Pacific.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type - Tier 1 – 62%, Tier 2 – 28%, and Tier 10
• By Designation – C-level – 62%, Director-level – 21%, and Others – 17%
• By Region – North America – 30%, Europe – 20%, Asia Pacific – 40%, and RoW – 10%

The key players in the advanced wound care market are Smith & Nephew (UK), Mölnlycke Health Care (Sweden), B. Braun (Germany), ConvaTec Group (US), Coloplast (Denmark), Integra LifeSciences (US), 3M Company (US), Cardinal Health (US), Acelity L.P. (US), Medtronic (US), MPM Medical (US), PAUL HARTMANN (Germany), Medline Industries (US), Lohmann & Rauscher (Germany), Advanced Medical Solutions Group (UK), BSN medical GmbH (Germany), Wound Care Technologies (US), Vivostat A/S (Denmark), Organogenesis (US), Hematris Wound Care (Germany), Alliqua BioMedical (UK), MiMedX Group (US), Triage Meditech (India), DeRoyal Industries (US), and Laboratoires URGO (UK).
Research Coverage:
The report analyses the advanced wound care market by product, wound type, end user, and region. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.
Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the advanced wound care market
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the advanced wound care market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the advanced wound care market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various advanced wound care products across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the advanced wound care market

TABLE OF CONTENTS

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.2.1 MARKETS COVERED 20
1.2.2 YEARS CONSIDERED FOR THE STUDY 21
1.3 CURRENCY 21
1.4 LIMITATIONS 21
1.5 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 SECONDARY DATA 23
2.1.1 KEY DATA FROM SECONDARY SOURCES 23
2.2 PRIMARY DATA 24
2.2.1 KEY DATA FROM PRIMARY SOURCES 24
2.3 MARKET SIZE ESTIMATION 25
2.3.1 BOTTOM-UP APPROACH 25
2.3.2 TOP-DOWN APPROACH 26
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.5 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 34
4.1 ADVANCED WOUND CARE: MARKET OVERVIEW 34
4.2 GEOGRAPHIC ANALYSIS: ADVANCED WOUND CARE MARKET,
BY REGION & WOUND TYPE (2017) 35
4.3 ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE, 2017–2022 36
4.4 GEOGRAPHICAL SNAPSHOT OF THE ADVANCED WOUND CARE MARKET 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Rising incidence of diabetes & associated chronic wounds 39
5.2.1.2 Rapid growth in the geriatric population 40
5.2.1.3 Increasing adoption of evidence-based treatments for chronic wounds 41
5.2.1.4 Innovation in advanced wound care products 41
5.2.1.5 Awareness programs for advanced wound care treatment and management 42
5.2.2 MARKET RESTRAINTS 42
5.2.2.1 High cost of advanced wound care products 42
5.2.3 MARKET OPPORTUNITIES 43
5.2.3.1 Increasing research and introduction of novel treatments for advanced wounds 43
5.2.3.2 Growth potential in emerging economies 43
6 GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT 44
6.1 INTRODUCTION 45
6.2 MOIST WOUND DRESSINGS 46
6.2.1 FOAM DRESSINGS 48
6.2.2 HYDROCOLLOID DRESSINGS 49
6.2.3 FILM DRESSINGS 50
6.2.4 ALGINATE DRESSINGS 51
6.2.5 HYDROGEL DRESSINGS 52
6.2.6 COLLAGEN DRESSINGS 53
6.3 WOUND THERAPY DEVICES 54
6.3.1 PRESSURE RELIEF DEVICES 56
6.3.2 NEGATIVE PRESSURE WOUND THERAPY SYSTEMS 57
6.3.3 HYPERBARIC OXYGEN EQUIPMENT 58
6.3.4 ELECTRICAL STIMULATION DEVICES 59
6.3.5 OTHER WOUND THERAPY DEVICES 60
6.4 ACTIVE WOUND CARE 61
6.4.1 ARTIFICIAL SKIN AND SUBSTITUTES 63
6.4.1.1 Autografts 65
6.4.1.2 Allografts and xenografts 66
6.4.1.3 Other substitutes 66
6.4.2 TOPICAL AGENTS 67
7 GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE 68
7.1 INTRODUCTION 69
7.2 SURGICAL WOUNDS 70
7.3 ULCERS 71
7.3.1 PRESSURE ULCERS 73
7.3.2 DIABETIC FOOT ULCERS 74
7.3.3 VENOUS ULCERS 75
7.4 TRAUMATIC WOUNDS 76
7.5 BURNS 77
7.6 OTHER WOUNDS 78

8 GLOBAL ADVANCED WOUND CARE MARKET, BY END USER 79
8.1 INTRODUCTION 80
8.2 HOSPITALS & CLINICS 81
8.3 HOME CARE SETTINGS 83
8.4 OTHER END USERS 84
9 ADVANCED WOUND CARE MARKET, BY REGION 85
9.1 INTRODUCTION 86
9.2 NORTH AMERICA 87
9.2.1 US 94
9.2.2 CANADA 98
9.2.3 MEXICO 103
9.3 EUROPE 107
9.3.1 GERMANY 114
9.3.2 FRANCE 118
9.3.3 UK 123
9.3.4 ITALY 127
9.3.5 SPAIN 131
9.3.6 REST OF EUROPE (ROE) 135
9.4 ASIA PACIFIC 139
9.4.1 CHINA 146
9.4.2 INDIA 150
9.4.3 JAPAN 154
9.4.4 AUSTRALIA 159
9.4.5 REST OF ASIA PACIFIC 164
9.5 REST OF THE WORLD 168
10 COMPETITIVE LANDSCAPE 176
10.1 INTRODUCTION 176
10.2 MARKET SHARE ANALYSIS 176
10.3 COMPETITIVE SITUATION AND TRENDS 177
10.3.1 PRODUCT LAUNCHES 178
10.3.2 AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS 179
10.3.3 EXPANSIONS 179
10.3.4 ACQUISITIONS 180

11 COMPANY PROFILES 181
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
11.1 SMITH & NEPHEW 181
11.2 MÖLNLYCKE HEALTH CARE (A PART OF INVESTOR AB) 184
11.3 B. BRAUN 187
11.4 CONVATEC GROUP 189
11.5 COLOPLAST 191
11.6 INTEGRA LIFESCIENCES 193
11.7 3M 195
11.8 CARDINAL HEALTH 197
11.9 MEDTRONIC 199
11.10 MIMEDX GROUP 201
11.11 MPM MEDICAL (RBC LIFE SCIENCES) 203
11.12 PAUL HARTMANN 205
11.13 ACELITY L.P. 207
11.14 KEY INNOVATORS 210
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 211
12.1 INSIGHTS FROM INDUSTRY EXPERTS 211
12.2 DISCUSSION GUIDE 212
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 215
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 217
12.5 AVAILABLE CUSTOMIZATIONS 219
12.6 RELATED REPORTS 219
12.7 AUTHOR DETAILS 220

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+